Moleculin Biotech Inc's Customers Performance

Name: Moleculin Biotech Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

MBRX

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


MBRX's Source of Revenues		• List of MBRX Customers

for the same period Moleculin Biotech Inc

• List of MBRX Customers

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Moleculin Biotech Inc's Comment on Sales, Marketing and Customers

The company is developing WP1066, a drug candidate that inhibits p-STAT3, targeting adult glioblastoma (GBM) and pediatric brain tumors, including Diffuse Intrinsic Pontine Glioma (DIPG). DIPG primarily affects children aged 6 to 9 years and accounts for 10-20% of pediatric gliomas, with an estimated 200 to 400 cases annually in the United States. There are currently no effective treatments for DIPG, which has a median survival of nine months after diagnosis. A study conducted at Emory University reported a positive response to WP1066 in a DIPG patient. In December 2020, the FDA granted WP1066 Rare Pediatric Disease designation, potentially qualifying the company for a Priority Review Voucher upon New Drug Application approval for certain indications.

Moleculin Biotech Inc’s Comment on Sales, Marketing and Customers

MBRX's Stock Performance relative to it's Customers

MBRX's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Moleculin Biotech Inc	4.97	0.00	-41.84	52
SUBTOTAL	0.00	0.00	0.00	-

Sources: Moleculin Biotech Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Moleculin Biotech Inc’s corporate clients.
For your research, we’ve provided 9 tables on Moleculin Biotech Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.